Clinical Trials in Bradenton, United States
Locations / Bradenton, United States
Delta Trials records 971 clinical trials conducted in Bradenton, United States, making it a notable site of clinical research activity. These trials across 780 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 103 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Bradenton has changed over time.
971
Total Trials
780
Conditions
103
Terminated since 2020
Browse by condition (780 total)
- Diabetes mellitus, type 2 46 trialsAll Diabetes mellitus, type 2 trials
- Alzheimer's disease 31 trialsAll Alzheimer's disease trials
- Schizophrenia 29 trialsAll Schizophrenia trials
- Major depressive disorder 28 trialsAll Major depressive disorder trials
- Attention deficit hyperactivity disorder 27 trialsAll Attention deficit hyperactivity disorder trials
- Hepatitis c, chronic 26 trialsAll Hepatitis c, chronic trials
- Diabetes 22 trialsAll Diabetes trials
- Heart failure 19 trialsAll Heart failure trials
- ADHD 15 trialsAll ADHD trials
- Multiple sclerosis 14 trialsAll Multiple sclerosis trials
- HIV infections 12 trialsAll HIV infections trials
- Hepatitis c 11 trialsAll Hepatitis c trials
- Type 2 diabetes mellitus 10 trialsAll Type 2 diabetes mellitus trials
- Alzheimer's disease 10 trialsAll Alzheimer's disease trials
- All Attention deficit hyperactivity disorder (adhd) trials
- Prostate cancer 10 trialsAll Prostate cancer trials
- Pain 10 trialsAll Pain trials
- Type 2 diabetes 9 trialsAll Type 2 diabetes trials
- Obesity 9 trialsAll Obesity trials
- Stroke 9 trialsAll Stroke trials